Literature DB >> 6234210

Increased concanavalin A induced suppression in treated and untreated coeliac disease.

C O'Farrelly, U McKeever, C Feighery, D G Weir.   

Abstract

The generation of suppression by concanavalin A in peripheral blood mononuclear cells in treated and untreated coeliac subjects using an in vitro assay was found to be significantly increased when compared with controls. The response of peripheral blood mononuclear cells to the plant mitogen concanavalin A (con A) was also significantly depressed in both groups of coeliac patients. It is proposed that the depressed cell mediated immunity found in this and other studies in coeliac patients is because of increased suppression. The possible connection between these findings and the increased incidence of malignancy also found in coeliac disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234210      PMCID: PMC1432378          DOI: 10.1136/gut.25.6.644

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Lymphocyte subpopulations in adult coeliac disease.

Authors:  A W Bullen; M S Losowsky
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

2.  Cellular and humoral sensitivity to gluten fractions in patients with treated nontropical sprue.

Authors:  J Morganroth; D W Watson; A B French
Journal:  Am J Dig Dis       Date:  1972-03

3.  Lymphoreticular dysfunction in idiopathic steatorrhoea.

Authors:  C F McCarthy; I D Fraser; K T Evans; A E Read
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

4.  Steatorrhea and malignant lymphoma. The relationship of malignant tumors of lymphoid tissue and celiac disease.

Authors:  W I Austad; J S Cornes; K R Gough; C F McCarthy; A E Read
Journal:  Am J Dig Dis       Date:  1967-05

5.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

6.  Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.

Authors:  A Ferguson; T T MacDonald; J P McClure; R J Holden
Journal:  Lancet       Date:  1975-04-19       Impact factor: 79.321

7.  Suppressor cell activity, splenic function and HLA B8 status in man.

Authors:  D A Robertson; A Bullen; H Field; F G Simpson; M S Losowsky
Journal:  J Clin Lab Immunol       Date:  1982-11

8.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

9.  Impaired lymphocyte reactivity against tumour cells in patients with coeliac disease.

Authors:  B P Maclaurin; W T Cooke; N R Ling
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  2 in total

1.  The microenvironment of coeliac disease: T cell phenotypes and expression of the T2 'T blast' antigen by small bowel lymphocytes.

Authors:  G Malizia; L K Trejdosiewicz; G M Wood; P D Howdle; G Janossy; M S Losowsky
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

2.  Gluten specific suppressor T cell dysfunction in coeliac disease.

Authors:  G R Corazza; P Sarchielli; M Londei; M Frisoni; G Gasbarrini
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.